{"id":"https://openalex.org/W4393097133","doi":"https://doi.org/10.1158/1538-7445.am2024-57","title":"Abstract 57: Ibrutinib improves chimeric antigen receptor T cell control of leukemia by inhibiting myeloid-derived suppressor cells","display_name":"Abstract 57: Ibrutinib improves chimeric antigen receptor T cell control of leukemia by inhibiting myeloid-derived suppressor cells","publication_year":2024,"publication_date":"2024-03-22","ids":{"openalex":"https://openalex.org/W4393097133","doi":"https://doi.org/10.1158/1538-7445.am2024-57"},"language":"en","primary_location":{"id":"doi:10.1158/1538-7445.am2024-57","doi":"https://doi.org/10.1158/1538-7445.am2024-57","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2024-57","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5062538044","display_name":"Benjamin F. Frost","orcid":"https://orcid.org/0009-0008-5251-5299","observed_orcids":["https://orcid.org/0009-0008-5251-5299"]},"institutions":[{"id":"https://openalex.org/I79576946","display_name":"University of Pennsylvania","ror":"https://ror.org/00b30xv10","country_code":"US","type":"education","lineage":["https://openalex.org/I79576946"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Benjamin F. Frost","raw_affiliation_strings":["1Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA;","institution_ids":["https://openalex.org/I79576946"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058378222","display_name":"Olga E. Shestova","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I79576946","display_name":"University of Pennsylvania","ror":"https://ror.org/00b30xv10","country_code":"US","type":"education","lineage":["https://openalex.org/I79576946"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Olga Shestova","raw_affiliation_strings":["2Department of Medicine, University of Pennsylvania, Philadelphia, PA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Department of Medicine, University of Pennsylvania, Philadelphia, PA;","institution_ids":["https://openalex.org/I79576946"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5044952624","display_name":"Feng Shen","orcid":"https://orcid.org/0000-0001-9634-6265","observed_orcids":["https://orcid.org/0000-0001-9634-6265"]},"institutions":[{"id":"https://openalex.org/I79576946","display_name":"University of Pennsylvania","ror":"https://ror.org/00b30xv10","country_code":"US","type":"education","lineage":["https://openalex.org/I79576946"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Feng Shen","raw_affiliation_strings":["2Department of Medicine, University of Pennsylvania, Philadelphia, PA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Department of Medicine, University of Pennsylvania, Philadelphia, PA;","institution_ids":["https://openalex.org/I79576946"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064967709","display_name":"Chia Sharpe","orcid":"https://orcid.org/0000-0001-7615-4442","observed_orcids":["https://orcid.org/0000-0001-7615-4442"]},"institutions":[{"id":"https://openalex.org/I63135867","display_name":"University of Cincinnati","ror":"https://ror.org/01e3m7079","country_code":"US","type":"education","lineage":["https://openalex.org/I63135867"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Chia Sharpe","raw_affiliation_strings":["3Department of Medicine, University of Cincinnati, Cincinnati, OH"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3Department of Medicine, University of Cincinnati, Cincinnati, OH","institution_ids":["https://openalex.org/I63135867"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069774776","display_name":"John C. Byrd","orcid":"https://orcid.org/0000-0002-8778-1000","observed_orcids":["https://orcid.org/0000-0002-8778-1000"]},"institutions":[{"id":"https://openalex.org/I63135867","display_name":"University of Cincinnati","ror":"https://ror.org/01e3m7079","country_code":"US","type":"education","lineage":["https://openalex.org/I63135867"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"John C. Byrd","raw_affiliation_strings":["3Department of Medicine, University of Cincinnati, Cincinnati, OH"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3Department of Medicine, University of Cincinnati, Cincinnati, OH","institution_ids":["https://openalex.org/I63135867"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5039491957","display_name":"Saar I. Gill","orcid":"https://orcid.org/0000-0001-7946-7778","observed_orcids":["https://orcid.org/0000-0001-7946-7778"]},"institutions":[{"id":"https://openalex.org/I79576946","display_name":"University of Pennsylvania","ror":"https://ror.org/00b30xv10","country_code":"US","type":"education","lineage":["https://openalex.org/I79576946"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Saar I. Gill","raw_affiliation_strings":["2Department of Medicine, University of Pennsylvania, Philadelphia, PA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Department of Medicine, University of Pennsylvania, Philadelphia, PA;","institution_ids":["https://openalex.org/I79576946"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":2,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"84","issue":"6_Supplement","first_page":"57","last_page":"57"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11491","display_name":"CAR-T cell therapy research","score":0.8378999829292297,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11491","display_name":"CAR-T cell therapy research","score":0.8378999829292297,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":0.1143999993801117,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.003800000064074993,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/ibrutinib","display_name":"ibrutinib","score":0.9909999966621399},{"id":"https://openalex.org/keywords/myeloid-derived-suppressor-cells","display_name":"myeloid-derived suppressor cells","score":0.8809999823570251},{"id":"https://openalex.org/keywords/car-t-cell-therapy","display_name":"CAR T-cell therapy","score":0.7400000095367432},{"id":"https://openalex.org/keywords/chronic-lymphocytic-leukemia","display_name":"chronic lymphocytic leukemia","score":0.9890000224113464},{"id":"https://openalex.org/keywords/btk-inhibition","display_name":"BTK inhibition","score":0.8510000109672546},{"id":"https://openalex.org/keywords/lymphodepletion","display_name":"lymphocyte depletion","score":0.9629999995231628},{"id":"https://openalex.org/keywords/immunosuppression","display_name":"immunosuppression","score":0.5960000157356262},{"id":"https://openalex.org/keywords/complete-response","display_name":"complete response","score":0.49300000071525574},{"id":"https://openalex.org/keywords/adoptive-t-cell-therapy","display_name":"adoptive T cell therapy","score":0.5730000138282776}],"concepts":[{"id":"https://openalex.org/C2779878957","wikidata":"https://www.wikidata.org/wiki/Q5984881","display_name":"Ibrutinib","level":4,"score":0.8610703945159912},{"id":"https://openalex.org/C3875195","wikidata":"https://www.wikidata.org/wiki/Q5099363","display_name":"Chimeric antigen receptor","level":4,"score":0.6631410121917725},{"id":"https://openalex.org/C2778729363","wikidata":"https://www.wikidata.org/wiki/Q11688946","display_name":"Myeloid leukemia","level":2,"score":0.6597250699996948},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5402964353561401},{"id":"https://openalex.org/C179185449","wikidata":"https://www.wikidata.org/wiki/Q219699","display_name":"Suppressor","level":3,"score":0.5238566398620605},{"id":"https://openalex.org/C2778461978","wikidata":"https://www.wikidata.org/wiki/Q29496","display_name":"Leukemia","level":2,"score":0.46759718656539917},{"id":"https://openalex.org/C147483822","wikidata":"https://www.wikidata.org/wiki/Q103537","display_name":"Antigen","level":2,"score":0.43637269735336304},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4311310648918152},{"id":"https://openalex.org/C2779282312","wikidata":"https://www.wikidata.org/wiki/Q1956561","display_name":"Myeloid","level":2,"score":0.4167637228965759},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.37825408577919006},{"id":"https://openalex.org/C2776090121","wikidata":"https://www.wikidata.org/wiki/Q193529","display_name":"T cell","level":3,"score":0.3623863756656647},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.19869673252105713},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.17261293530464172},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.14672210812568665},{"id":"https://openalex.org/C2777938653","wikidata":"https://www.wikidata.org/wiki/Q1088156","display_name":"Chronic lymphocytic leukemia","level":3,"score":0.08080598711967468}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1538-7445.am2024-57","doi":"https://doi.org/10.1158/1538-7445.am2024-57","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2024-57","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4405043108","https://openalex.org/W2909491225","https://openalex.org/W4405047600","https://openalex.org/W3042495231","https://openalex.org/W2983183442","https://openalex.org/W2476363078","https://openalex.org/W2950496791","https://openalex.org/W3010073081","https://openalex.org/W2276096997","https://openalex.org/W2547611457"],"abstract_inverted_index":{"Abstract":[0],"Background:":[1],"In":[2,200,217],"patients":[3,66],"with":[4,67,160,177,207,210,233,252,265,273,299,317],"chronic":[5],"lymphocytic":[6],"leukemia":[7,364],"(CLL),":[8],"we":[9,115,165],"and":[10,89,99,131,142,181,225,312],"others":[11],"have":[12],"shown":[13,74],"that":[14,84,280],"the":[15,18,26,108,127,137,144,147,167,238,374],"addition":[16],"of":[17,28,59,86,96,110,123,129,146,152,172,231,240,250,305,326,335,363,373],"BTK":[19,70,297],"inhibitor":[20],"ibrutinib":[21,87,111,135,178,185,300,321],"to":[22,75,136,149],"CART":[23,44,97,102,161,306,323,336],"cells":[24,62,98,125,236,259,307,369],"increases":[25],"rates":[27],"durable":[29],"complete":[30],"responses.":[31],"The":[32],"mechanism":[33],"for":[34,43,195,377],"this":[35,226],"remains":[36],"unknown.":[37],"Lymphodepletion":[38],"(LD)":[39],"is":[40],"considered":[41],"critical":[42],"cell":[45,103,303,324,361],"therapy":[46],"success,":[47],"yet":[48],"emergency":[49],"myelopoiesis":[50],"during":[51,88],"recovery":[52],"from":[53,192,237,261],"LD":[54,91,277],"may":[55],"induce":[56],"a":[57,276,289],"surge":[58],"myeloid-derived":[60,367],"suppressor":[61,368],"(MDSC),":[63],"particularly":[64],"in":[65,79,120,126,162,196,281,308,310,328],"advanced":[68],"cancer.":[69],"inhibition":[71,298],"has":[72],"been":[73],"inhibit":[76,150],"MDSC":[77,221,232],"function":[78,198,246],"vitro.":[80],"We":[81,133],"therefore":[82],"hypothesized":[83],"administration":[85],"following":[90],"could":[92],"reduce":[93],"MDSC-mediated":[94,333],"suppression":[95,304,334],"thereby":[100],"improve":[101],"outcomes.":[104],"Methods:":[105],"To":[106,156],"explore":[107],"effects":[109],"on":[112,139],"human":[113,153,220,311],"MDSCs,":[114],"engineered":[116],"suppressive":[117,268],"monocytes":[118,148],"through":[119],"vitro":[121,197,218,309],"culture":[122,138],"CD14+":[124],"presence":[128],"IL-6":[130],"GM-CSF.":[132],"added":[134],"Days":[140],"0-4":[141],"compared":[143],"ability":[145],"proliferation":[151],"CAR-T":[154],"cells.":[155,337],"model":[157,171],"CLL":[158,327],"treatment":[159,251],"immunocompetent":[163],"mice,":[164],"used":[166],"Em-TCL1":[168],"adaptive":[169],"transfer":[170],"CLL.":[173],"Mice":[174],"were":[175,190,204],"treated":[176,206,264,272],"(I),":[179],"cyclophosphamide":[180],"fludarabine":[182],"(FC),":[183,320],"or":[184,211,214,254],"+":[186],"FC":[187,213,253],"(FC+I).":[188],"MDSCs":[189],"isolated":[191],"these":[193],"mice":[194,203,242,263,271],"studies.":[199],"subsequent":[201],"experiments":[202],"also":[205],"syngeneic":[208,244],"CART19":[209,223,245,274],"without":[212],"FC+I.":[215],"Results:":[216],"generated":[219],"suppressed":[222],"function,":[224],"was":[227],"prevented":[228],"by":[229,331,365],"pre-treatment":[230],"ibrutinib.":[234],"Myeloid":[235],"spleens":[239],"CLL-bearing":[241,262],"inhibited":[243],"ex":[247],"vivo":[248],"regardless":[249],"I":[255],"alone,":[256],"but":[257],"myeloid":[258,302],"harvested":[260],"FC+I":[266],"lost":[267],"function.":[269],"Finally,":[270],"after":[275],"regimen":[278],"resembling":[279],"our":[282],"recently":[283],"reported":[284],"clinical":[285],"trial":[286],"(FC+I)":[287],"showed":[288],"survival":[290],"advantage":[291],"over":[292],"all":[293],"other":[294],"groups.":[295],"Conclusions:":[296],"prevents":[301],"murine":[313],"systems.":[314],"When":[315],"combined":[316],"lymphodepleting":[318],"chemotherapy":[319],"enhances":[322],"control":[325,362],"vivo,":[329],"possibly":[330],"preventing":[332],"Citation":[338],"Format:":[339],"Benjamin":[340],"F.":[341],"Frost,":[342],"Olga":[343],"Shestova,":[344],"Feng":[345],"Shen,":[346],"Chia":[347],"Sharpe,":[348],"John":[349],"C.":[350],"Byrd,":[351],"Saar":[352],"I.":[353],"Gill.":[354],"Ibrutinib":[355],"improves":[356],"chimeric":[357],"antigen":[358],"receptor":[359],"T":[360],"inhibiting":[366],"[abstract].":[370],"In:":[371],"Proceedings":[372],"American":[375],"Association":[376],"Cancer":[378,396],"Research":[379],"Annual":[380],"Meeting":[381],"2024;":[382],"Part":[383],"1":[384],"(Regular":[385],"Abstracts);":[386],"2024":[387],"Apr":[388],"5-10;":[389],"San":[390],"Diego,":[391],"CA.":[392],"Philadelphia":[393],"(PA):":[394],"AACR;":[395],"Res":[397],"2024;84(6_Suppl):Abstract":[398],"nr":[399],"57.":[400]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2024-03-23T00:00:00"}